Who Paid My Doc
Flucelvax Quadrivalent
Biological Vaccines
NDC 70461-421-10
General payments
$315,542
Research payments
$109,962
Through program year 2023, $315,542 in general payments and $109,962 in research payments were reported against Flucelvax Quadrivalent (Vaccines).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $169,610 | 4,720 |
| 2023 | Research | $1,500 | 1 |
| 2022 | General | $110,793 | 5,063 |
| 2022 | Research | $14,785 | 1 |
| 2021 | General | $35,139 | 1,930 |
| 2021 | Research | $93,678 | 19 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2023.
The top 5 of 87 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
The top 5 of 46 states; each share is of general payments naming this product in 2023 where a state was reported.
Records
11,713 general · 21 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.